Addex Therapeutics ADXN
NASDAQ ADXN
$2.99 +0.01 (+0.33%)
As of: Oct 2, 2026 · 10:46 AM EDT

Addex Therapeutics (ADXN) Return on Equity [ROE] (2020 - 2026)

Updated

Addex Therapeutics (ADXN) recorded Return on Equity [ROE] of -260.63% in Q2 2026, down 182.37 percentage points from -78.26% a year earlier and down 89.48 percentage points from the prior quarter.

Analysis

Addex Therapeutics (ADXN) Return on Equity [ROE] (2020 - 2026) Analysis & Trends

For FY2025, Addex Therapeutics reported Return on Equity [ROE] of -99.24%, down 229.75 percentage points from FY2024.

  • Annual Return on Equity [ROE] has a five-year change of -31.43 percentage points (FY2020 to FY2025).
  • Across earlier years, Return on Equity [ROE] came in at 130.50% in FY2024 (+502.91 pp), -372.41% in FY2023 (-188.32 pp), -184.09% in FY2022 (-87.64 pp) and -96.45% in FY2021 (-28.64 pp).
  • The Q2 2026 figure is the lowest quarterly Return on Equity [ROE] since Q4 2023.
  • On a year-over-year basis, Return on Equity [ROE] has declined for five consecutive quarters, with an average year-over-year change of +82.21 percentage points over the last seven quarters.
  • Peak year-over-year performance for Return on Equity [ROE] in the last five years was a gain of 773.62 percentage points in Q4 2024, against a drop of 559.00 percentage points in Q1 2023 at the low end.
  • Per Business Quant, the preceding three quarters came in at -171.15% (Q1 2026), -121.49% (Q4 2025) and -89.42% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 25.32%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 7.21%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 84.40%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 21.39%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 83.75%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -18.38%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 4.97%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 22.24%
10 Addex Therapeutics 2.47 Mn 2.47 Mn - -260.63%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -260.63%
Mar 31, 2026 -170.85%
Dec 31, 2025 -121.26%
Sep 30, 2025 -89.23%
Jun 30, 2025 -78.09%
Mar 31, 2025 93.33%
Dec 31, 2024 63.51%
Sep 30, 2024 -22.14%
Jun 30, 2024 -66.99%
Dec 31, 2023 -710.12%
Sep 30, 2023 -534.37%
Jun 30, 2023 -560.43%
Mar 31, 2023 -756.70%
Dec 31, 2022 -594.78%
Sep 30, 2022 -451.94%
Jun 30, 2022 -324.98%
Mar 31, 2022 -197.70%
Dec 31, 2021 -174.09%
Sep 30, 2021 -161.07%
Jun 30, 2021 -126.57%
API Access

Addex Therapeutics Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=ADXN&period=max&api_key=YOUR_API_KEY